A securities class action has been filed against Ardent Health Inc., alleging the company and certain executives made false or misleading statements and failed to disclose issues related to accounts receivable collectability and revenue recognition. The suit follows Ardent’s disclosure of a $43 million third-quarter 2025 revenue decrease tied to revised collectability determinations after a transition to a new revenue accounting system, alongside a cut to 2025 EBITDA guidance and a $54 million increase in professional liability reserves. Investors seeking to be appointed lead plaintiff must file by April 21, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202602242117NEWSFILECNPR____20260224_285105_1) on February 25, 2026, and is solely responsible for the information contained therein.